Researchers at Vanderbilt University have developed two new chemical compounds. These compounds are designed to investigate the TAOK protein family, which has been linked to Alzheimer's disease. The first compound, VU6083859, is a selective inhibitor of TAOK-1. The second compound, VU6080195, activates all three proteins in the TAOK family.
Alzheimer's disease is the leading cause of dementia. It affects over seven million people in the United States. Current treatments primarily address symptoms. There is no cure for the disease.
Understanding the underlying biology of Alzheimer's disease is a significant challenge. Scientists use tool compounds to study proteins. These compounds can increase or decrease protein activity. This research can lead to new treatment developments.
TAOK-1 is a protein associated with Alzheimer's disease. Its function has been difficult to study due to a lack of specific research tools. The new selective inhibitor, VU6083859, provides a way to investigate TAOK-1's role. The pan-TAOK activator, VU6080195, offers an unexpected tool to study the effects of increased TAOK protein activity.
These compounds allow scientists to explore the TAOK protein family more deeply. This research could uncover hidden disease mechanisms. It may also lead to new treatment strategies for Alzheimer's and other neurological conditions. The findings were published in *ACS Chemical Neuroscience*.
Related stories
Accelerated Biological Aging Linked to Rising Early-Onset Cancer Rates
New research links accelerated biological aging in younger generations to a higher risk of early-onset cancers, suggesting bodies may be aging faster than chronological age.
Low Vitamin D Linked to Increased Post-Surgery Pain
A study found breast cancer patients with low vitamin D experienced more pain and used more opioids after mastectomy, suggesting a link between vitamin D and post-surgical recovery.
Alzheimer's Disease Linked to Altered 3D Genome Organization
A new study reveals that the 3D organization of DNA is disrupted in brain cells affected by Alzheimer's disease, altering gene activity.